CALABRETTA, Bruno

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

Nome completo

CALABRETTA, Bruno

Afferenza

Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa

Pubblicazioni

Risultati 1 - 20 di 246 (tempo di esecuzione: 0.001 secondi).

	Titolo	Data di pubblicazione	Autore(i)
1	A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.	1988	Gewirtz, Am; Calabretta, Bruno
2	A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element.	1996	Perrotti, D; Bellón, T; Trotta, R; Martinez, R; Calabretta, Bruno
3	A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells	2007	Corradini, Francesca; Bussolari, Rita; Cerioli, D; Lidonnici, Mr; Calabretta, Bruno
4	A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.	1992	Skórski, T; Nieborowska Skórska, M; CALABRETTA, Bruno
5	Activation of human B-MYB by cyclins.	1997	Sala, A; Kundu, M; Casella, I; Engelhard, A; Calabretta, Bruno; Grasso, L; Paggi, Mg; Giordano, A; Watson, Rj; Khalili, K; Peschle, C.
6	Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.	1999	Majewski, M; Nieborowska Skorska, M; Salomoni, Paolo; Slupianek, A; Reiss, K; Trotta, R; Calabretta, Bruno; Skorski, T.
7	Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide	2008	Vitali, R; Cesi, V; Tanno, B; Ferrari, Giovanna; Dominici, C; Calabretta, Bruno; Raschellà, G.
8	Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model	2009	Vitali, R; Mancini, C; Cesi, V; Tanno, B; Piscitelli, M; Mancuso, M; Sesti, F; Pasquali, E; Calabretta, Bruno; Dominici, C; Raschellà, G.
9	Altered expression of G1 specific genes in human malignant myeloid cells.	1986	Calabretta, Bruno; D., Venturelli; L., Kaczmarek; Narni, Franco; M., Talpaz; B., Anderson; M., Beran; R., Baserga
10	Altered expression of growth-regulated protooncogenes in human malignant plasma cells.	1989	Palumbo, Ap; Pileri, A; Dianzani, U; Massaia, M; Boccadoro, M; Calabretta, Bruno
11	Altered mRNA translation: possible mechanism for CML disease progression.	2003	Perrotti, D; Trotta, R; Calabretta, Bruno
12	An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.	1989	Anfossi, G; Gewirtz, Am; Calabretta, Bruno
13	Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo	1997	Skorski, T; Perrotti, D; Nieborowska Skorska, M; Gryaznov, S; Calabretta, Bruno
14	Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.	1994	Smetsers, Tf; Skorski, T; van de Locht, Lt; Wessels, Hm; Pennings, Ah; de Witte, T; Calabretta, Bruno; Mensink, E. J.
15	Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.	1991	Valtieri, M; Venturelli, D; Caré, A; Fossati, C; Pelosi, E; Labbaye, C; Mattia, G; Gewirtz, Am; Calabretta, Bruno; Peschle, C.
16	Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice.	2006	Skorski, T; Nieborowska Skorska, M; Wlodarski, P; Zon, G; Iozzo, Rv; Calabretta, Bruno
17	Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?	1995	de Fabritiis, P; Calabretta, Bruno
18	Antisense oligonucleotides.	1992	Calabretta, Bruno; Skorski, T; Zon, G.
19	Antisense strategies in the treatment of leukemias.	1996	Calabretta, Bruno; Skorski, T; Ratajczak, Mz; Gewirtz, A. M.
20	Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.	1996	Leonetti, C; D'Agnano, I; Lozupone, F; Valentini, A; Geiser, T; Zon, G; Calabretta, Bruno; Citro G., C; Zupi, G.